GSK-2261818A

N/A

Report date: 2022/05/25 16:22:54
NME

Base Information

Drug NameGSK-2261818A
Drug Alias NameGSK-2261818AGSK-2261818-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis signal-regulating kinase 1 inhibitors
TargetsApoptosis signal-regulating kinase 1
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A